Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with London

Journal of Psychiatric and Mental Health Nursing

Volumn 15, Issue 9, 2008, Pages 758-766

  Patel, M X ^a   Yeung, F K K ^b   Haddad, P M ^c   David, A S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Mental Health Association of Hong Kong   (Hong Kong)

^c GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antipsychotic agents; Attitude; Delayed action preparations; Health personnel; Hong Kong; Injections; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; COST OF ILLNESS; DELAYED RELEASE FORMULATION; ECONOMICS; HEALTH PERSONNEL ATTITUDE; HONG KONG; HUMAN; INJECTION; NURSE PATIENT RELATIONSHIP; NURSING; ORAL DRUG ADMINISTRATION; PSYCHIATRIC NURSING; PSYCHOSIS; QUESTIONNAIRE; REPRODUCIBILITY; UNITED KINGDOM;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; COST OF ILLNESS; DELAYED-ACTION PREPARATIONS; HONG KONG; HUMANS; INJECTIONS; LONDON; NURSE-PATIENT RELATIONS; PSYCHIATRIC NURSING; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 53349102622     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/j.1365-2850.2008.01306.x     Document Type: Article

References (32)

1. Adams C.E., Fenton M.K., Quraishi S., et al 2001) Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. British Journal of Psychiatry 179, 290 299.
2. Adewuya A.O., Ola B.A., Mosaku S.K., et al 2006) Attitudes towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatrica Scandinavica 113, 207 211.
3. Bennett J., Done J. Hunt B. (1995) Assessing the side-effects of antipsychotic drugs: a survey of CPN practice. Journal of Psychiatric and Mental Health Nursing 2, 177 182.
4. Day J.C., Wood G., Dewey M., et al 1995) A self-rating scale for measuring neuroleptic side-effects: validation in a group of schizophrenic patients. British Journal of Psychiatry 166, 650 653.
5. Dencker S.J. Axelsson R. (1996) Optimising the use of depot antipsychotics. CNS Drugs 6, 367 381.
6. Dunn G. (1989) Design and Analysis of Reliability Studies: The Statistical Evaluation of Measurement Errors. Edward Arnold, London.
7. Freudenreich O., Cather C., Evins A.E., et al 2004) Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. Journal of Clinical Psychiatry 65, 1372 1376.
8. Gerlach J. Larson E.B. (1999) Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica 99 (Suppl. 395 113 117.
9. Glazer W.M. Kane J.M. (1992) Depot neuroleptic therapy: an underutilized treatment option. Journal of Clinical Psychiatry 53, 426 433.
10. Gray R. (1998) Primary care of Schizophrenia: what are the roles of practice and community psychiatric nurses. Community Mental Health 1, 5 7.
11. Hellewell J.S.E. (2002) Patients' subjective experiences of antipsychotics - Clinical relevance. CNS Drugs 16, 457 471.
12. Heres S., Hamann J., Kissling W., et al 2006) Attitudes of psychiatrists toward antipsychotic depot medication. Journal of Clinical Psychiatry 67, 1948 53.
13. Heres S., Schmitz F., Leucht S., et al 2007) The attitude of patients towards antipsychotic depot treatment. International Clinical Psychopharmacology 22, 275 82.
14. Hofer A., Kemmler G., Eder U., et al 2004) Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication and side effects. Journal of Clinical Psychiatry 65, 932 939.
15. Kane J.M., Aguglia E., Altamura A.C., et al 1998) Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology 8, 55 66.
16. Lambert T., Brennan A., Castle D., et al 2003) Perception of depot antipsychotics by mental health professionals. Journal of Psychiatric Practice 9, 252 260.
17. Lambert T.J., Callaly T., Wheeler A., et al 2005) The use of depot antipsychotics in cross cultural settings: relationship to polyantipsychotic and polypsychotropic prescribing. Schizophrenia Bulletin 31, 544.
18. Marland G.R. Sharkey V. (1999) Depot neuroleptics, schizophrenia and the role of the nurse: is practice evidence based? A review of the literature. Journal of Advanced Nursing 30, 1255 1262.
19. Niaz O. Haddad P.M. (2007) 35 months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of inpatient care. Acta Psychiatrica Scandinavica 116, 36 46.
20. Patel M.X. David A.S. (2005) Why aren't depots prescribed more often, and what can be done about it? Advances in Psychiatric Treatment 11, 203 213.
21. Patel M.X., Nikolaou V. David A.S. (2003) Psychiatrists attitudes to maintenance medication for patients with schizophrenia. Psychological Medicine 33, 83 89.
22. Patel M.X., De Zoysa N., Baker D., et al 2005) Depot antipsychotic medication and attitudes of community psychiatric nurses. Journal of Psychiatric and Mental Health Nursing 12, 237 244.
23. Patel M.X., deZoysa N., Bernadt M., et al 2008a) Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. Journal of Psychopharmacology (in Press).
24. Patel M.X., deZoysa N., Bernadt M., et al 2008b) Patients' perspectives on adherence to antipsychotic medication: depots versus tablets. Journal of Clinical Psychiatry (in Press).
25. Sajatovic M., Rosch D.S., Sivec H.J., et al 2002) Insight into illness and attitudes towards medications among inpatients with schizophrenia. Psychiatric Services 53, 1319 1321.
26. Svedberg B., Hallstrom T. Lutzen K. (2000) The morality of treating patients with depot neuroleptics: the experience of community psychiatric nurses. Nursing Ethics 7, 35 46.
27. Taylor D., Mir S., Mace S., et al 1999) Is Cost a Factor-II? A Survey of Psychiatrists and Health Authorities to Determine the Factors Influencing the Prescribing and Funding of Atypical Antipsychotics. National Schizophrenia Fellowship, London.
28. Turner G. (1993) Client/CPN contact during the administration of depot medications: implications for practice. In : Community Psychiatric Nursing: A Research Perspective Vol. 2 (eds Brooker, C. White, E. pp. 71 100. Chapman & Hall, London.
29. Van Putten T., May P.R.A., Marder S.R., et al 1981) Subjective response to antipsychotic drugs. Archives of General Psychiatry 38, 187 190.
30. Walburn J., Gray R., Gournay K., et al 2001) Systematic Review of patient and nurse attitudes to depot antipsychotic medication. British Journal of Psychiatry 179, 300 307.
31. Weiden P.J. Olfson M. (1995) Cost of relapse in schizophrenia. Schizophrenia Bulletin 21, 419 29.
32. Zygmunt A., Olfson M., Boyer C.A., et al 2002) Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry 159, 1653 1664.